| Festuccia C, Gravina GL, Biordi L, et al.
Effects of EGFR tyrosine kinase inhibitor erlotinib in prostate cancer cells in vitro. [JOURNAL ARTICLE]
Prostate 2009 Jun 26.
Abstract | Full Citation | | Akaza H, Hinotsu S, Usami M, et al.
Combined androgen blockade with bicalutamide for advanced prostate cancer: long-Term Follow-Up of a Phase 3, Double-Blind, Randomized Study for Survival. [JOURNAL ARTICLE]
Cancer 2009 Jun 17.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | De Amicis F, Thirugnansampanthan J, Cui Y, et al.
Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells. [JOURNAL ARTICLE]
Breast Cancer Res Treat 2009 Jun 17.
Abstract | Full Citation | | Bolla M, de Reijke TM, Van Tienhoven G, et al.
Duration of androgen suppression in the treatment of prostate cancer. [Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
N Engl J Med 2009 Jun 11; 360(24):2516-27.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bedognetti D, Rubagotti A, Conti G, et al.
An Open, Randomised, Multicentre, Phase 3 Trial Comparing the Efficacy of Two Tamoxifen Schedules in Preventing Gynaecomastia Induced by Bicalutamide Monotherapy in Prostate Cancer Patients. [JOURNAL ARTICLE]
Eur Urol 2009 May 19.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ehara H, Katoh S, Nakane K, et al.
[Clinical usefulness of chlormadinone acetate as an alternative antiandrogen therapy for prostate cancer relapse after combined androgen blockade therapy] [English Abstract, Journal Article]
Hinyokika Kiyo 2009 Apr; 55(4):199-203.
Abstract | Full Citation | Find Related Articles | | Kashimshetty R, Desai VG, Kale VM, et al.
Underlying mitochondrial dysfunction triggers flutamide-induced oxidative liver injury in a mouse model of idiosyncratic drug toxicity. [JOURNAL ARTICLE]
Toxicol Appl Pharmacol 2009 May 11.
Abstract | Full Citation | Find Related Articles | | Locke JA, Nelson CC, Adomat HH, et al.
Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts. [JOURNAL ARTICLE]
J Steroid Biochem Mol Biol 2009 Apr 5.
Abstract | Full Citation | | Gunther JR, Parent AA, Katzenellenbogen JA
Alternative Inhibition of Androgen Receptor Signaling: Peptidomimetic Pyrimidines As Direct Androgen Receptor/Coactivator Disruptors. [JOURNAL ARTICLE]
ACS Chem Biol 2009 May 14.
Abstract | Full Citation | Find Related Articles | | Pang B, Zhang H, Wang J, et al.
Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression. [JOURNAL ARTICLE]
Prostate 2009 May 4.
Abstract | Full Citation |   |
|
| |
Advertise on this site.
|
